Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior

Detalhes bibliográficos
Autor(a) principal: Farinha-Ferreira, Miguel
Data de Publicação: 2022
Outros Autores: Rei, Nádia, Fonseca-Gomes, João, Miranda-Lourenço, Catarina, Serrão, Paula, Vaz, Sandra H., Gomes, Joana I., Martins, Valéria, de Alves Pereira, Beatriz, Sebastião, Ana M.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/151392
Resumo: Funding Information: Work was supported by project funding from Fundação para a Ciência e para a Tecnologia (FCT) ( PTDC/MED-FAR/30933/2017 and PTDC/MED-FAR/4834/2021 ) and by H2020-WIDESPREAD-05-2017-Twinning (EpiEpinet) under grant agreement No. 952455 . MF-F ( SFRH/BD/147505/2019 ), NR ( PD/BD/113463/2015 ), JF-G ( PD/BD/114441/2016 ) and CM-L ( SFRH/BD/118238/2016 ) are supported by PhD fellowships from FCT . The funding sources had no involvement in study design, preparation of the manuscript, or decision regarding its submission. Publisher Copyright: © 2022
id RCAP_7c9a6d7aa62fd5c201e274a903829758
oai_identifier_str oai:run.unl.pt:10362/151392
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behaviorAdolescenceAnxietyCannabinoidsDepressionHU-210StressPharmacologyCellular and Molecular NeuroscienceFunding Information: Work was supported by project funding from Fundação para a Ciência e para a Tecnologia (FCT) ( PTDC/MED-FAR/30933/2017 and PTDC/MED-FAR/4834/2021 ) and by H2020-WIDESPREAD-05-2017-Twinning (EpiEpinet) under grant agreement No. 952455 . MF-F ( SFRH/BD/147505/2019 ), NR ( PD/BD/113463/2015 ), JF-G ( PD/BD/114441/2016 ) and CM-L ( SFRH/BD/118238/2016 ) are supported by PhD fellowships from FCT . The funding sources had no involvement in study design, preparation of the manuscript, or decision regarding its submission. Publisher Copyright: © 2022Chronic adolescent cannabinoid receptor agonist exposure has been shown to lead to persistent increases in depressive-like behaviors. This has been a key obstacle to the development of cannabinoid-based therapeutics. However, most of the published work has been performed with only three compounds, namely Δ9-tetrahydrocannabinol, CP55,940 and WIN55,212–2. Hypothesizing that different compounds may lead to distinct outcomes, we herein used the highly potent CB1R/CB2R full agonist HU-210, and first aimed at replicating cannabinoid-induced long-lasting effects, by exposing adolescent female Sprague-Dawley rats to increasing doses of HU-210, for 11 days and testing them at adulthood, after a 30-day drug washout. Surprisingly, HU-210 did not significantly impact adult anxious- or depressive-like behaviors. We then tested whether chronic adolescent HU-210 treatment resulted in short-term (24h) alterations in depressive-like behavior. Remarkably, HU-210 treatment simultaneously induced marked antidepressant- and prodepressant-like responses, in the modified forced swim (mFST) and sucrose preference tests (SPT), respectively. Hypothesizing that mFST results were a misleading artifact of HU-210-induced behavioral hyperreactivity to stress, we assessed plasmatic noradrenaline and corticosterone levels, under basal conditions and following an acute swim-stress episode. Notably, we found that while HU-210 did not alter basal noradrenaline or corticosterone levels, it greatly augmented the stress-induced increase in both. Our results show that, contrary to previously studied cannabinoid receptor agonists, HU-210 does not induce persisting depressive-like alterations, despite inducing marked short-term increases in stress-induced reactivity. By showing that not all cannabinoid receptor agonists may induce long-term negative effects, these results hold significant relevance for the development of cannabinoid-based therapeutics.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Centro de Estudos de Doenças Crónicas (CEDOC)RUNFarinha-Ferreira, MiguelRei, NádiaFonseca-Gomes, JoãoMiranda-Lourenço, CatarinaSerrão, PaulaVaz, Sandra H.Gomes, Joana I.Martins, Valériade Alves Pereira, BeatrizSebastião, Ana M.2023-03-29T22:22:38Z2022-08-152022-08-15T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/151392eng0028-3908PURE: 57246873https://doi.org/10.1016/j.neuropharm.2022.109155info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:33:50Zoai:run.unl.pt:10362/151392Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:54:34.361020Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior
title Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior
spellingShingle Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior
Farinha-Ferreira, Miguel
Adolescence
Anxiety
Cannabinoids
Depression
HU-210
Stress
Pharmacology
Cellular and Molecular Neuroscience
title_short Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior
title_full Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior
title_fullStr Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior
title_full_unstemmed Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior
title_sort Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior
author Farinha-Ferreira, Miguel
author_facet Farinha-Ferreira, Miguel
Rei, Nádia
Fonseca-Gomes, João
Miranda-Lourenço, Catarina
Serrão, Paula
Vaz, Sandra H.
Gomes, Joana I.
Martins, Valéria
de Alves Pereira, Beatriz
Sebastião, Ana M.
author_role author
author2 Rei, Nádia
Fonseca-Gomes, João
Miranda-Lourenço, Catarina
Serrão, Paula
Vaz, Sandra H.
Gomes, Joana I.
Martins, Valéria
de Alves Pereira, Beatriz
Sebastião, Ana M.
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
Centro de Estudos de Doenças Crónicas (CEDOC)
RUN
dc.contributor.author.fl_str_mv Farinha-Ferreira, Miguel
Rei, Nádia
Fonseca-Gomes, João
Miranda-Lourenço, Catarina
Serrão, Paula
Vaz, Sandra H.
Gomes, Joana I.
Martins, Valéria
de Alves Pereira, Beatriz
Sebastião, Ana M.
dc.subject.por.fl_str_mv Adolescence
Anxiety
Cannabinoids
Depression
HU-210
Stress
Pharmacology
Cellular and Molecular Neuroscience
topic Adolescence
Anxiety
Cannabinoids
Depression
HU-210
Stress
Pharmacology
Cellular and Molecular Neuroscience
description Funding Information: Work was supported by project funding from Fundação para a Ciência e para a Tecnologia (FCT) ( PTDC/MED-FAR/30933/2017 and PTDC/MED-FAR/4834/2021 ) and by H2020-WIDESPREAD-05-2017-Twinning (EpiEpinet) under grant agreement No. 952455 . MF-F ( SFRH/BD/147505/2019 ), NR ( PD/BD/113463/2015 ), JF-G ( PD/BD/114441/2016 ) and CM-L ( SFRH/BD/118238/2016 ) are supported by PhD fellowships from FCT . The funding sources had no involvement in study design, preparation of the manuscript, or decision regarding its submission. Publisher Copyright: © 2022
publishDate 2022
dc.date.none.fl_str_mv 2022-08-15
2022-08-15T00:00:00Z
2023-03-29T22:22:38Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/151392
url http://hdl.handle.net/10362/151392
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0028-3908
PURE: 57246873
https://doi.org/10.1016/j.neuropharm.2022.109155
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138134561128448